Hàn Quốc điều tra nguyên nhân nhiều người tử vong sau khi tiêm vắcxin

Ngày 5/11, Cơ quan Phòng và Kiểm soát dịch bệnh (KDCA) của Hàn Quốc thông báo hiện có 94 người, phần lớn là người cao tuổi, đã tử vong sau khi tiêm vắcxin phòng cúm mùa. Tuy nhiên, cơ quan này cũng đồng thời khẳng định nguyên nhân gây tử vong ở 87 ca có liên quan rất ít tới việc tiêm phòng. Những trường hợp tử vong còn lại đang tiếp tục được điều tra.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh